Research Articles
The Hidden Players in Leukemia: How BCR-ABL Splice Variants Challenge Targeted Therapy
Exploring how BCR-ABL splice variants in chronic myeloid leukemia create treatment resistance and challenge targeted therapy approaches.
The Genetic Detectives: Unraveling Cyclophosphamide Resistance in Childhood Leukemia
Exploring the genetic basis of cyclophosphamide resistance in pediatric leukemia through advanced genomic profiling and its implications for personalized medicine.
Decoding Busulfan Resistance in Pediatric Leukemia: A Genomic Revolution
How cutting-edge genome science is uncovering the reasons why some childhood leukemias resist chemotherapy.
Tiny Messengers of Mayhem: How Childhood Leukemia Cells Hijack Cell Communication
Discover how pediatric leukemia cells use exosomes to manipulate cell communication and fuel cancer growth through paracrine and autocrine signaling.
Cracking Leukemia's Code: How a Genetic Signature is Revolutionizing B-ALL Treatment
Discover how the ID1/ID3/IGJ genetic signature is transforming B-cell Acute Lymphoblastic Leukemia treatment through personalized medicine approaches.
The Inside Job: How a Molecular Double-Act Drives an Aggressive Blood Cancer
Discover how PRL-3 and LEO1 proteins work together to drive Acute Myelogenous Leukemia (AML) and the promising new therapeutic approaches targeting this molecular partnership.
Cracking the Cancer Shield: How Childhood Leukemia Outsmarts Chemotherapy
Discover how childhood leukemia develops resistance to chemotherapy and the groundbreaking research uncovering genetic mechanisms to overcome treatment resistance.
Unlocking Genes: How Mivebresib Reprograms Cancer Cells in Aggressive Leukemia
Exploring biomarker modulation by mivebresib in relapsed/refractory acute myeloid leukemia - a breakthrough in epigenetic therapy
The Silent Battle Within: How Computational Intelligence is Revolutionizing Leukemia Detection
Exploring how computational intelligence is transforming leukemia diagnosis through AI, machine learning, and optimization algorithms.
The Silent Saboteur: How a Tiny RNA Molecule Drives Aggressive Leukemia
Discover how U1 spliceosomal RNA mutations drive aggressive leukemia through splicing dysregulation and their potential as therapeutic targets.